TranScrip Portfolio Management and Commercial Strategy

Companies of all sizes need to make timely decisions to ensure that in-house portfolio and in-licensing projects achieve long-term commercial success and profitability. TranScrip’s scientific, clinical and commercial experts have the appropriate therapeutic knowledge and strategic insights to advise and guide clients on internal pipeline and external opportunities as part of their portfolio management to ensure maximisation of commercial opportunities.


TranScrip Portfolio Management and Commercial Strategy Experts

TranScrip’s Portfolio Management and Commercial Strategy team has worked on assessment of in-house and in-licensing opportunities for clients of all sizes. These assessments have covered all phases of development and extend across a wide variety of therapeutic areas. TranScrip is able to mobilise multifunctional teams with appropriate therapeutic, operational and / or strategic expertise to quickly and efficiently help clients with their future decision making.

Tim Joslin
Head of Portfolio Management and Commercial Strategy

Tim leads the TranScrip Portfolio Management and Commercial Strategy team in the provision of the services relating to the evaluation, selection, and prioritisation of product development to maximise value creation.

Tim and his team have performed a multitude of assessments of in-licensing opportunities as well as providing extensive support to the launch and medical affairs aspects across a range of products and therapeutic areas. He has extensive experience in the pharmaceutical industry in commercial roles, including leading product strategy teams in national and global launches of several antibiotics and respiratory compounds.

Case Study

This case study presents an example of TranScrip’s role in gaining an investment decision leading to the implementation of clinical development.


An investment house needed an assessment of a company portfolio of pre-clinical candidates and the potential for return of investment in the therapeutic area to enable a major funding decision.


TranScrip Partners performed a comprehensive review of the therapeutic area including competitive intelligence and assessment of drug candidates.


A positive investment decision was made and the clinical development programme started, with TranScrip Partners providing clinical development support.

TranScrip Partners provide Portfolio Management and Commercial Strategy support across various therapeutic areas to include:

Data review and gap analysis

Review and analysis of Target Product Profiles

Assessment of medical need and commercial viability

Assessment of benefit/risk profiles

Creation/review of regulatory and development strategies

Identification of key milestones in the development programme